Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
5.86
+0.01 (0.17%)
Nov 5, 2024, 11:14 AM EST - Market open

Relay Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Revenue
35.2125.551.383.0382.65-
Upgrade
Revenue Growth (YoY)
3637.58%1749.82%-54.41%-96.34%--
Upgrade
Cost of Revenue
329.75326.39243.01169.3996.59-
Upgrade
Gross Profit
-294.55-300.84-241.62-166.36-13.94-
Upgrade
Selling, General & Admin
78.8278.5869.3359.7541.8616.96
Upgrade
Research & Development
-----67.09
Upgrade
Operating Expenses
78.8278.5869.3359.7541.8684.05
Upgrade
Operating Income
-373.37-379.42-310.95-226.11-55.8-84.05
Upgrade
Interest & Investment Income
34.0431.058.790.833.48.8
Upgrade
Other Non Operating Income (Expenses)
0.02-0.02-0.02-0-0.02-0.06
Upgrade
EBT Excluding Unusual Items
-339.3-348.4-302.19-225.28-52.41-75.31
Upgrade
Merger & Restructuring Charges
----0.9--
Upgrade
Gain (Loss) on Sale of Investments
----11.86--
Upgrade
Other Unusual Items
16.476.4211.68-2.84--
Upgrade
Pretax Income
-322.83-341.97-290.51-363.87-52.41-75.31
Upgrade
Net Income
-322.83-341.97-290.51-363.87-52.41-75.31
Upgrade
Preferred Dividends & Other Adjustments
----177.79-
Upgrade
Net Income to Common
-322.83-341.97-290.51-363.87-230.2-75.31
Upgrade
Shares Outstanding (Basic)
12812311295433
Upgrade
Shares Outstanding (Diluted)
12812311295433
Upgrade
Shares Change (YoY)
7.57%9.22%17.97%123.22%1135.17%38.84%
Upgrade
EPS (Basic)
-2.53-2.79-2.59-3.82-5.40-21.82
Upgrade
EPS (Diluted)
-2.53-2.79-2.59-3.82-5.40-21.82
Upgrade
Free Cash Flow
-283.24-304.44-238.55-77.88-104.42-74.14
Upgrade
Free Cash Flow Per Share
-2.22-2.48-2.13-0.82-2.45-21.49
Upgrade
Gross Margin
-----16.86%-
Upgrade
Operating Margin
-1060.46%-1485.25%-22516.44%-7464.74%-67.51%-
Upgrade
Profit Margin
-916.92%-1338.66%-21036.13%-12012.94%-278.51%-
Upgrade
Free Cash Flow Margin
-804.48%-1191.74%-17273.86%-2571.05%-126.33%-
Upgrade
EBITDA
-367.87-374.15-306.82-222.18-52.25-81.2
Upgrade
EBITDA Margin
-----63.21%-
Upgrade
D&A For EBITDA
5.55.274.133.933.552.85
Upgrade
EBIT
-373.37-379.42-310.95-226.11-55.8-84.05
Upgrade
EBIT Margin
-----67.51%-
Upgrade
Revenue as Reported
35.2125.551.383.0382.65-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.